help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on October 9, 2003, doi:10.1164/rccm.200304-558OC

Am. J. Respir. Crit. Care Med., Volume 169, Number 2, January 2004, 174-179

A more recent version of this article appeared on January 15, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200304-558OCv1
169/2/174    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilljam, M.
Right arrow Articles by Tullis, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilljam, M.
Right arrow Articles by Tullis, D. E.

Submitted on April 22, 2003
Accepted on October 6, 2003

Airway Inflammation and Infection in Congenital Bilateral Absence of the Vas Deferens

Marita Gilljam1, Yuri Moltyaner2, Gregory P Downey3, Roslyn Devlin4, Peter Durie5, Andre M Cantin6, Julian Zielenski7, and D. Elizabeth Tullis2*

1 Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Goteborg University, Goteborg, Sweden, 2 Adult Cystic Fibrosis Centre, St Michael's Hospital, Toronto, Ontario, Canada; Medicine, Division of Respirology, University of Toronto, Toronto, Ontario, Canada, 3 Toronto General Hospital Reseach Institute, Toronto, Ontario, Canada; Medicine, Division of Respirology, University of Toronto, Toronto, Ontario, Canada, 4 Diagnostic Laboratories and Pathobiology, St Michael's Hospital, Toronto, Ontario, Canada, 5 Research Institute, Hospital For Sick Children, Toronto, Ontario, Canada; Pediatrics, University of Toronto, Toronto, Ontario, Canada, 6 Medicine, Division of Respirology, University of Sherbrooke, Sherbrooke, Quebec, Canada, 7 Research Institute, Hospital For Sick Children, Toronto, Ontario, Canada; Medical and Molecular Genetics, University of Toronto, Toronto, Ontario, Canada

* To whom correspondence should be addressed. E-mail: tullise{at}smh.toronto.on.ca.

In cystic fibrosis (CF), airway disease begins early in life. Bacteria and elevated levels of neutrophils and inflammatory mediators have been detected in bronchoalveolar lavage (BAL) fluid from infants with CF. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) are common in men with congenital bilateral absence of the vas deferens (CBAVD) and it has been suggested that this syndrome represent a mild form of CF. We hypothesized that men with CBAVD also have subclinical pulmonary disease. Bronchoscopy with BAL with viral and quantitative bacterial cultures and analyses of total and differential cell count, cytokines and free neutrophil elastase was performed in 8 men with CBAVD, who had mutations in CFTR and intermediate or elevated sweat chloride levels, and in 4 healthy controls. There was light growth of Staphylococcus aureus in 1/8 and small numbers of gram-negative bacteria in 6/8 men with CBAVD and in one control subject. BAL cell counts and neutrophil elastase were within the normal range. IL-8 and TNF{alpha} levels were higher for CBAVD than for controls. These data suggest that mutations in CFTR in men with CBAVD, in addition to causing infertility, lead to subclinical bacterial pulmonary infection and inflammation consistent with mild CF.


Key words: Cystic fibrosis, bronchoalveolar lavage, inflammation, infection, cystic fibrosis transmembrane conductance regulator




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Wilschanski, A. Dupuis, L. Ellis, K. Jarvi, J. Zielenski, E. Tullis, S. Martin, M. Corey, L.-C. Tsui, and P. Durie
Mutations in the Cystic Fibrosis Transmembrane Regulator Gene and In Vivo Transepithelial Potentials
Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 787 - 794.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
B. P. O'Sullivan, R. G. Zwerdling, H. L. Dorkin, A. M. Comeau, and R. Parad
Early Pulmonary Manifestation of Cystic Fibrosis in Children With the {Delta}F508/R117H-7T Genotype
Pediatrics, September 1, 2006; 118(3): 1260 - 1265.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Bush, F. Accurso, W. MacNee, S. C. Lazarus, and E. Abraham
Cystic Fibrosis, Pediatrics, Control of Breathing, Pulmonary Physiology and Anatomy, and Surfactant Biology in AJRCCM in 2004
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 545 - 553.
[Full Text] [PDF]


Home page
ChestHome page
M. Gilljam, L. Ellis, M. Corey, J. Zielenski, P. Durie, and D. E. Tullis
Clinical Manifestations of Cystic Fibrosis Among Patients With Diagnosis in Adulthood
Chest, October 1, 2004; 126(4): 1215 - 1224.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
U. Pradal and G. L. Piacentini
Cystic Fibrosis Patients, Infertile Men, and Their Noses
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 141 - 142.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society
  ATS 2008 State of the Art Course